[1]谭焜月 刘春霞 熊峰.急性心肌梗死后微循环障碍的非药物治疗研究进展[J].心血管病学进展,2019,(8):1104-1107.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.008]
　TAN Kunyue,LIU Chunxia,XIONG Feng.Non-drug Treatment of Coronary Microvascular Dysfunction after Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(8):1104-1107.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.008]
点击复制

急性心肌梗死后微循环障碍的非药物治疗研究进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2019年8期
页码:
1104-1107
栏目:
综述
出版日期:
2019-11-25

文章信息/Info

Title:
Non-drug Treatment of Coronary Microvascular Dysfunction after Acute Myocardial Infarction
作者:
谭焜月 刘春霞 熊峰
(成都市第三人民医院 成都市心血管病研究所,四川 成都 610031)
Author(s):
TAN Kunyue;  LIU Chunxia;  XIONG Feng
( Chengdu Cardiovascular Research InstituteThe Third People’s Hospital of ChengduChengdu 610031SichuanChina)
关键词:
急性心肌梗死; 冠状动脉微循环障碍; 经皮冠脉介入
Keywords:
Acute myocardial infarctionMicrovascular dysfunction;  Percutaneous coronary intervention
DOI:
10.16806/j.cnki.issn.1004-3934.2019.08.008
摘要:
经皮冠脉介入是急性心肌梗死的重要治疗手段，但常规冠状动脉介入治疗能处理大血管病变，术后易发生微循环障碍（CMD）。药物治疗虽能一定程度上改善CMD，但疗效有限。随着近年来有创及无创技术的发展，后CMD的治疗有了新的进展。综述后CMD的非药物治疗研究进展，以期探索最佳治疗策略。
Abstract:
Percutaneous coronary intervention is an important treatment for acute myocardial infarctionbut it can only treat macroangiopathy. Coronary microangiopathy also play an important role on acute myocardial infarction. Drugs can improve coronary microcirculation dysfunction(CMD) to some extent,but the effect is limited. Along with the developments of recent non-invasive and invasive techniques,treatment of CMD keeps going deeper. This paper reviews the treatment progress of CMD,and hopes to explore the best treatment strategy．

参考文献/References:


[1] Diez-Delhoyo F,Gutierrez-Ibanes E,Loughlin G,et al. Coronary physiology assessment in the catheterization laboratory[J]. World J Cardiol,2015,7(9):525-538.
[2] Marc MC,Iancu AC,Balanescu S,et al. Microvascular obstruction in acute myocardial infarction:an old and unsolved mystery[J]. Med Pharm Rep,2019,92(3):216-219.
[3] Niccoli G,Scalone G,Lerman A,et al. Coronary microvascular obstruction in acute myocardial infarction[J]. Eur Heart J,2016,37(13):1024-1033.
[4] O’Neill WW,Martin JL,Dixon SR,et al. Therapy (AMIHOT):a prospective,randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention[J]. J Am Coll Cardiol,2007,50(5):397-405.
[5] Stone GW,Martin JL,de Boer MJ,et al. Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction[J]. Circ Cardiovasc Interv,2009,2(5):366-375.
[6] Hanson ID,David SW,Dixon SR,et al. "Optimized" delivery of intracoronary supersaturated oxygen in acute anterior myocardial infarction:a feasibility and safety study[J]. Catheter Cardiovasc Interv,2015,86 Suppl 1:S51-57.
[7] David SW,Khan ZA,Patel NC,et al. Evaluation of intracoronary hyperoxemic oxygen therapy in acute anterior myocardial infarction:The IC-HOT study[J]. Catheter Cardiovasc Interv,2019,93(5),882-890.
[8] van de Hoef TP,Nijveldt R,van der Ent M,et al. Pressure-controlled intermittent coronary sinus occlusion (PICSO) in acute ST-segment elevation myocardial infarction:results of the Prepare RAMSES safety and feasibility study[J]. EuroIntervention,2015,11(1):37-44.
[9] de Maria GL,Alkhalil M,Borlotti A,et al. Index of microcirculatory resistance-guided therapy with pressure-controlled intermittent coronary sinus occlusion improves coronary microvascular function and reduces infarct size in patients with ST-elevation myocardial infarction:the Oxford Acute Myocardial Infarction-Pressure-controlled Intermittent Coronary Sinus Occlusion study (OxAMI-PICSO)[J]. EuroIntervention, 2018,14(3):e352-e359.
[10] 吴英乐,董平栓. 主动脉球囊反搏最新临床研究回顾[J]. 心血管病学进展, 2014,35(4):461-464.
[11] Patel MR,Smalling RW,Thiele H,et al. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock:the CRISP AMI randomized trial[J]. JAMA,2011,306(12):1329-1337.
[12] Slikkerveer J,Kleijn SA,Appelman Y,et al. Ultrasound enhanced prehospital thrombolysis using microbubbles infusion in patients with acute ST elevation myocardial infarction:pilot of the Sonolysis study[J]. Ultrasound Med Biol,2012,38(2):247-252.
[13] Mathias W Jr,Tsutsui JM,Tavares BG,et al. Diagnostic ultrasound impulses improve microvascular flow in patients with STEMI receiving intravenous microbubbles[J]. J Am Coll Cardiol,2016,67(21):2506-2515.
[14] Mathias W Jr,Tsutsui JM,Tavares BG,et al. Sonothrombolysis in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention[J].J Am Coll Cardiol,2019,73(22):2832-2842.
[15] Lagerqvist B,Frobert O,Olivecrona GK,et al. Outcomes 1 year after thrombus aspiration for myocardial infarction[J]. N Engl J Med,2014,371(12):1111-1120.
[16] Jolly SS,Cairns JA,Yusuf S,et al. Outcomes after thrombus aspiration for ST elevation myocardial infarction:1-year follow-up of the prospective randomised TOTAL trial[J]. Lancet,2016,387(10014):127-135.
[17] Sharma V,Jolly SS,Hamid T,et al. Myocardial blush and microvascular reperfusion following manual thrombectomy during percutaneous coronary intervention for ST elevation myocardial infarction:insights from the TOTAL trial[J]. Eur Heart J,2016,37(24):1891-1898.
[18] Elgendy AY,Elgendy IY,Mahmoud AN,et al. Long-term outcomes with aspiration thrombectomy for patients undergoing primary percutaneous coronary intervention:a meta-analysis of randomized trials[J]. Clin Cardiol,2017,40(8):534-541.
[19] Arslan F,Bongartz L,Ten Berg JM,et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:comments from the Dutch ACS working group[J]. Neth Heart J,2018,26(9),417-421.
[20] Kunadian B,Dunning J,Vijayalakshmi K,et al. Meta-analysis of randomized trials comparing anti-embolic devices with standard PCI for improving myocardial reperfusion in patients with acute myocardial infarction[J]. Catheter Cardiovasc Interv,2007,69(4):488-496.
[21] Hibi K,Kozuma K,Sonoda S,et al. A randomized study of distal filter protection versus conventional treatment during percutaneous coronary intervention in patients with attenuated plaque identified by intravascular ultrasound[J]. JACC Cardiovasc Interv,2018,11(16):1545-1555.[22] 李群星,尹德录. 急性心肌梗死低温治疗研究进展[J]. 心血管病学进展, 2019,40(2):264-267.
[23] Erlinge D,Gotberg M,Noc M,et al. Therapeutic hypothermia for the treatment of acute myocardial infarction-combined analysis of the RAPID MI-ICE and the CHILL-MI trials[J]. Ther Hypothermia Temp Manag,2015,5(2):77-84.
[24] Nichol G,Strickland W,Shavelle D,et al. Prospective,multicenter,randomized,controlled pilot trial of peritoneal hypothermia in patients with ST-segment-elevation myocardial infarction[J]. Circ Cardiovasc Interv,2015,8(3):e001965.
[25] Dae M,O’Neill W,Grines C,et al. Effects of endovascular cooling on infarct size in ST-segment elevation myocardial infarction:a patient-level pooled analysis from randomized trials[J]. J Interv Cardiol,2018,31(3):269-276.
[26] McGarvey M,Ali O,Iqbal MB,et al. A feasibility and safety study of intracoronary hemodilution during primary coronary angioplasty in order to reduce reperfusion injury in myocardial infarction[J]. Catheter Cardiovasc Interv,2018,91(2):234-241.
[27] Crea F,Bairey Merz CN,Beltrame JF,et al. Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization[J]. Eur Heart J,2019,40(29):2455-2462.

相似文献/References:

[1]林远龙,刘现亮.无复流现象:从基础到临床[J].心血管病学进展,2016,(1):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
　LIN Yuanlong,LIU Xianliang.From Bench to Bed:No-reflow Phenomenon[J].Advances in Cardiovascular Diseases,2016,(8):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
[2]赵劲东,综述,董平栓,等.合并多支血管病变的急性ST段抬高型心肌梗死介入术治疗策略的研究进展[J].心血管病学进展,2016,(3):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
　ZHAO Jindong,DONG Pingshuan.Research Progress of Interventional Therapy in Patients with ST-elevation Myocardial Infarction and Multivessel Disease[J].Advances in Cardiovascular Diseases,2016,(8):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
[3]余正春,综述,马小静,等.急性心肌梗死并发心源性休克的治疗进展[J].心血管病学进展,2016,(4):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
　YU Zhengchun,MA Xiaojing.Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(8):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
[4]袁帅,毛玉琳,钱志敏,等.经皮冠脉介入术在高龄老年患者治疗中的研究新进展[J].心血管病学进展,2019,(6):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
　YUAN Shuai,MAO Yulin,QIAN Zhimin,et al.New Progress in Study of PCI in treatment of Elderly Patients[J].Advances in Cardiovascular Diseases,2019,(8):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
[5]元洋洋 李波.Selvester QRS评分系统研究进展[J].心血管病学进展,2019,(7):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
　YUAN YangyangLI Bo.Research Progress of Selvester QRS Scoring System[J].Advances in Cardiovascular Diseases,2019,(8):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
[6]翁子骞 于波.血栓抽吸在急性ST段抬高型心肌梗死中的研究进展[J].心血管病学进展,2019,(7):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
　WENG ZiqianYU Bo.Thrombus aspiration in acute ST-segment elevation myocardial infarction[J].Advances in Cardiovascular Diseases,2019,(8):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
[7]林莉 韦铁民.急性心肌梗死后心脏破裂[J].心血管病学进展,2019,(7):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
　LIN LiWEI Tiemin.Post-infarction Cardiac Rupture[J].Advances in Cardiovascular Diseases,2019,(8):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
[8]杨颜瑜,苏星,谭敏,等.炎症指标与急性心肌梗死研究进展[J].心血管病学进展,2019,(6):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
　YANG Yanyu,SU Xing,TAN Min,et al.Relationship Between Inflammation Index and Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(8):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
[9]崔小豪 杨志明.和肽素在急性心肌梗死中的研究进展[J].心血管病学进展,2019,(5):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
　CUI Xiaohao,YANG Zhiming.Copeptin in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(8):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
[10]潘甜 马康华.急性心肌梗死经皮冠脉介入术后冠状动脉无复流的预防和治疗进展[J].心血管病学进展,2019,(5):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
　PAN Tian,MA Kanghua.Prevention and Treatment of Coronary Artery No-Reflow after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(8):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]

备注/Memo

备注/Memo:
收稿日期：2019-09-12
更新日期/Last Update: 2020-01-19